GPCR

NASDAQStock

Structure Therapeutics Inc.

$55.10-3.17 (-5.45%)

52-Week Range

$14.15
$93.79

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

-1.90

Volume

322.6K

Avg Volume

790.9K

Performance

1M

-25.91%

3M

-13.21%

6M

+188.12%

YTD

-14.56%

1Y

+171.71%

3Y

+151.30%

5Y

+123.85%

Price Chart

ETF Exposure

GPCR is held by 17 ETFs

ETFFund NameWeight
LRNZTRUESHARES TECHNOLOGY, AI & DEEP LEARNING ETF3.31%
OZEMRoundhill Investments - GLP-1 & Weight Loss ETF2.67%
WDNAWisdomTree BioRevolution Fund2.56%
SBIOALPS Medical Breakthroughs ETF2.27%
FDGAmerican Century Focused Dynamic Growth ETF1.03%
BBCVirtus Biotech Clinical Trials ETF0.64%
FMEDFIDELITY DISRUPTIVE MEDICINE ETF0.62%
HRTSTema Cardiovascular and Metabolic ETF0.51%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF0.32%
EWXState Street SPDR S&P Emerging Markets Small Cap ETF0.32%
IBBQInvesco Nasdaq Biotechnology ETF0.29%
GDOCGoldman Sachs Future Health Care Equity ETF0.29%
TNXTT. Rowe Price Innovation Leaders ETF0.29%
IBBiShares Biotechnology ETF0.27%
BIBProShares - Ultra Nasdaq Biotechnology0.20%
GXCState Street SPDR S&P China ETF0.08%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%

About GPCR ETF Exposure

Structure Therapeutics Inc. (GPCR) is held by 17 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $55.10. Investors can gain exposure to GPCR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GPCR, sorted by portfolio weight.